...
首页> 外文期刊>Cellular and molecular life sciences: CMLS >Extracellular vesicle isolation methods: rising impact of size-exclusion chromatography
【24h】

Extracellular vesicle isolation methods: rising impact of size-exclusion chromatography

机译:细胞外囊泡隔离方法:尺寸排除色谱的升高影响

获取原文
获取原文并翻译 | 示例
           

摘要

Extracellular vesicles (EVs) include a variety of nanosized vesicles released to the extracellular microenvironment by the vast majority of cells transferring bioactive lipids, proteins, mRNA, miRNA or non-coding RNA, as means of intercellular communication. Remarkably, among other fields of research, their use has become promising for immunomodulation, tissue repair and as source for novel disease-specific molecular signatures or biomarkers. However, a major challenge is to define accurate, reliable and easily implemented techniques for EV isolation due to their nanoscale size and high heterogeneity. In this context, differential ultracentrifugation (dUC) has been the most widely used laboratory methodology, but alternative procedures have emerged to allow purer EV preparations with easy implementation. Here, we present and discuss the most used of the different EV isolation methods, focusing on the increasing impact of size exclusion chromatography (SEC) on the resulting EV preparations from in vitro cultured cells-conditioned medium and biological fluids. Comparatively, low protein content and cryo-electron microscopy analysis show that SEC removes most of the overabundant soluble plasma proteins, which are not discarded using dUC or precipitating agents, while being more user friendly and less time-consuming than gradient-based EV isolation. Also, SEC highly maintains the major EVs' characteristics, including vesicular structure and content, which guarantee forthcoming applications. In sum, together with scaling-up possibilities to increase EV recovery and manufacturing following high-quality standards, SEC could be easily adapted to most laboratories to assist EV-associated biomarker discovery and to deliver innovative cell-free immunomodulatory and pro-regenerative therapies.
机译:细胞外囊泡(EVS)包括通过绝大多数细胞传递生物活性脂质,蛋白质,mRNA,非编码RNA作为细胞间通信的手段释放到细胞外微环境的各种纳米囊泡。值得注意的是,除其他领域之外,它们的使用已经对免疫调节,组织修复和新颖的疾病特异性分子签名或生物标志物的来源有望。然而,由于其纳米级尺寸和高异质性,主要挑战是定义准确,可靠且容易地实现的EV隔离技术。在这种情况下,差动超速离心(DUC)是最广泛使用的实验室方法,但已经出现了替代程序,以允许更容易实施的熔种EV准备。在这里,我们展示并讨论了最多使用的不同EV隔离方法,专注于尺寸排阻色谱(SEC)对来自体外培养的细胞调节培养基和生物流体的EV制剂的增加。相对轻地,低蛋白质含量和低温电子显微镜分析表明,SEC除去大部分过遍的可溶性血浆蛋白,这些蛋白质不会使用DUC或沉淀剂丢弃,而比基于梯度的EV隔离更友好,耗时越少。此外,SEC也高度维持了主要的EVS的特点,包括湿润结构和内容,保证即将到来的应用。总之,随着高质量标准增加EV恢复和制造的扩大可能性,SES可以很容易地适应大多数实验室,以协助EV相关的生物标志物发现,并提供创新的无细胞免疫调节和促再生疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号